Dynamics of Increasing IFN-γ Exposure on Murine MH-S Cell-Line Alveolar Macrophage Phagocytosis of Streptococcus pneumoniae

Journal of Interferon and Cytokine Research

Volumn 35, Issue 6, 2015, Pages 474-479

  Mina, Michael J ^a,b   Brown, Lou Ann S ^a   Klugman, Keith P ^b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON;

ANIMAL CELL; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL COUNT; BACTERIAL STRAIN; BACTERIUM COLONY; CELL KINETICS; CELL PHAGOCYTOSIS; COLONY FORMING UNIT; CONTROLLED STUDY; FLUORESCENCE MICROSCOPY; INTERNALIZATION; LUNG ALVEOLUS MACROPHAGE; MACROPHAGE FUNCTION; MOUSE; NONHUMAN; PHENOTYPE; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE; ANIMAL; CELL LINE; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGY; MICROBIOLOGY; PHAGOCYTOSIS; TIME FACTOR;

BACTERIA (MICROORGANISMS); MURINAE; STREPTOCOCCUS PNEUMONIAE;

ANIMALS; CELL LINE; INTERFERON-GAMMA; MACROPHAGES, ALVEOLAR; MICE; PHAGOCYTOSIS; STREPTOCOCCUS PNEUMONIAE; TIME FACTORS;

EID: 84931041065     PISSN: 10799907     EISSN: 15577465     Source Type: Journal    
DOI: 10.1089/jir.2014.0087     Document Type: Article

References (21)

1. Arredouani M, Yang Z, Ning Y, Qin G, Soininen R, Tryggvason K, Kobzik L. 2004. The scavenger receptor MARCO is required for lung defense against pneumococcal pneumonia and inhaled particles. J Exp Med 200(2):267-272.
2. Chow OA, von Kockritz-Blickwede M, Bright AT, Hensler ME, Zinkernagel AS, Cogen AL, Gallo RL, Monestier M, Wang Y, Glass CK, Nizet V. 2010. Statins enhance formation of phagocyte extracellular traps. Cell Host Microbe 8(5):445-454.
3. Chroneos Z, Shepherd VL. 1995. Differential regulation of the mannose and SP-A receptors on macrophages. Am J Physiol 269(6 Pt 1):L721-L726.
4. Gordon SB, Irving GR, Lawson RA, Lee ME, Read RC. 2000. Intracellular trafficking and killing of Streptococcus pneumoniae by human alveolar macrophages are influenced by opsonins. Infect Immun 68(4):2286-2293.
5. Hernandez-Arriaga AM, Espinosa M, del Solar G. 2012. Fitness of the pMV158 replicon in Streptococcus pneumoniae. Plasmid 67(2):162-166.
6. Kraal G, van der Laan LJ, Elomaa O, Tryggvason K. 2000. The macrophage receptor MARCO. Microbes Infect 2(3):313-316.
7. Mancuso P, Standiford TJ, Marshall T, Peters-Golden M. 1998. 5-Lipoxygenase reaction products modulate alveolar macrophage phagocytosis of Klebsiella pneumoniae. Infect Immun 66(11):5140-5146.
8. Mbawuike IN, Herscowitz HB. 1989. MH-S, a murine alveolar macrophage cell line: morphological, cytochemical, and functional characteristics. J Leukoc Biol 46(2):119-127.
9. McCullers JA. 2006. Insights into the interaction between influenza virus and pneumococcus. Clin Microbiol Rev 19(3): 571-582.
10. Mosser DM. 2003. The many faces of macrophage activation. J Leukoc Biol 73(2):209-212.
11. Mosser DM, Edwards JP. 2008. Exploring the full spectrum of macrophage activation. Nat Rev Immunol 8(12):958-969.
12. Mosser DM, Handman E. 1992. Treatment of murine macrophages with interferon-gamma inhibits their ability to bind leishmania promastigotes. J Leukoc Biol 52(4):369-376.
13. Munder M, Mallo M, Eichmann K, Modolell M. 2001. Direct stimulation of macrophages by IL-12 and IL-18-A bridge built on solid ground. Immunol Lett 75(2):159-160.
14. Nieto C, Espinosa M. 2003. Construction of the mobilizable plasmid pMV158GFP, a derivative of pMV158 that carries the gene encoding the green fluorescent protein. Plasmid 49(3):281-285.
15. Otani T, Nakamura S, Toki M, Motoda R, Kurimoto M, Orita K. 1999. Identification of IFN-gamma-producing cells in IL-12/IL-18-treated mice. Cell Immunol 198(2):111-119.
16. Schroder K, Hertzog PJ, Ravasi T, Hume DA. 2004. Interferongamma: an overview of signals, mechanisms and functions. J Leukoc Biol 75(2):163-189.
17. Sun K, Metzger DW. 2008. Inhibition of pulmonary antibacterial defense by interferon-gamma during recovery from influenza infection. Nat Med 14(5):558-564.
18. Tabrizi SN, Robins-Browne RM. 1993. Elimination of extracellular bacteria by antibiotics in quantitative assays of bacterial ingestion and killing by phagocytes. J Immunol Methods 158(2):201-206.
19. Trost M, English L, Lemieux S, Courcelles M, Desjardins M, Thibault P. 2009. The phagosomal proteome in interferongamma-activated macrophages. Immunity 30(1):143-154.
20. Yates RM, Hermetter A, Taylor GA, Russell DG. 2007. Macrophage activation downregulates the degradative capacity of the phagosome. Traffic 8(3):241-250.
21. Zhou H, Kobzik L. 2007. Effect of concentrated ambient particles on macrophage phagocytosis and killing of Streptococcus pneumoniae. Am J Respir Cell Mol Biol 36(4): 460-465.